Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Bristol › NPI 1538763636
Lab

Vistalink Health Laboratories LLC

Vistalink Health Laboratories LLC was paid $5.68M by Medicaid between Jan 2021 and Jun 2023, across 10 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 61% of everything it billed.

33Billing provider infoVISTALINK HEALTH LABORATORIES LLC
BRISTOL, VA 24201
33aNPI1538763636assigned 11/30/2020
28Total paid$5.68M
24GClaims160,079
24DCodes billed10
24AFirst – last monthJan 2021 – Jun 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Virginia

Rank by total paid#7 of 78
Median peer was paid$37K
This provider vs. median154×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202148,040$1.68M
202296,265$3.37M
202315,774$624K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 61% 53,093 12,595 $3.46M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 20% 52,482 12,547 $1.13M
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 19% 52,954 12,601 $1.07M
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 817 453 $4K
80053 Comprehensive metabolic panel <1% 374 320 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 39 33 $2K
80061 Lipid panel <1% 114 108 $954.42
83036 Hemoglobin; glycosylated (A1C) <1% 145 137 $946.72
84443 Thyroid stimulating hormone (TSH) <1% 45 41 $430.08
80048 Basic metabolic panel (calcium, ionized) <1% 16 16 $87.88

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGAMBILL, CHRISTOPHER (COO)